Cargando…

Prognostic Biomarkers for Survival in Nasopharyngeal Carcinoma: A Systematic Review of the Literature

SIMPLE SUMMARY: Nasopharyngeal carcinoma (NPC) is an important Epstein–Barr virus (EBV)-associated malignancy. Currently, tumor–nodes–metastases (TNM) staging and tumor markers, such as EBV DNA, are widely used for prognostication; however, the identification of novel molecular biomarkers, especiall...

Descripción completa

Detalles Bibliográficos
Autores principales:	Islam, Kazi Anisha, Chow, Larry Ka-Yue, Kam, Ngar Woon, Wang, Ying, Chiang, Chi Leung, Choi, Horace Cheuk-Wai, Xia, Yun-Fei, Lee, Anne Wing-Mui, Ng, Wai Tong, Dai, Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Systematic Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9103785/ https://www.ncbi.nlm.nih.gov/pubmed/35565251 http://dx.doi.org/10.3390/cancers14092122

Ejemplares similares

Prognostication of Half-Life Clearance of Plasma EBV DNA in Previously Untreated Non-metastatic Nasopharyngeal Carcinoma Treated With Radical Intensity-Modulated Radiation Therapy
por: Chan, Sik-Kwan, et al.
Publicado: (2020)

Prognostic Factors for Overall Survival in Nasopharyngeal Cancer and Implication for TNM Staging by UICC: A Systematic Review of the Literature
por: Chiang, Chi Leung, et al.
Publicado: (2021)

Treatment-Related Adverse Events of Combination EGFR Tyrosine Kinase Inhibitor and Immune Checkpoint Inhibitor in EGFR-Mutant Advanced Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis
por: Chan, Daisy Wai-Ka, et al.
Publicado: (2022)

External Validation of a Nomogram to Predict Survival and Benefit of Concurrent Chemoradiation for Stage II Nasopharyngeal Carcinoma
por: Yip, Pui-Lam, et al.
Publicado: (2021)

An Exploratory Study of Refining TNM-8 M1 Categories and Prognostic Subgroups Using Plasma EBV DNA for Previously Untreated De Novo Metastatic Nasopharyngeal Carcinoma
por: Chan, Sik-Kwan, et al.
Publicado: (2022)

Efficacy, safety, and correlative biomarkers of bintrafusp alfa in recurrent or metastatic nasopharyngeal cancer patients: a phase II clinical trial
por: Chiang, Chi Leung, et al.
Publicado: (2023)

Incidence and Demographics of Nasopharyngeal Carcinoma in Cheung Chau Island of Hong Kong—A Distinct Geographical Area With Minimal Residential Mobility and Restricted Public Healthcare Referral Network
por: Chan, Sik-Kwan, et al.
Publicado: (2021)

The Most Efficacious Induction Chemotherapy Regimen for Locoregionally Advanced Nasopharyngeal Carcinoma: A Network Meta-Analysis
por: Choi, Horace Cheuk-Wai, et al.
Publicado: (2021)

Prognostication of serial post-intensity-modulated radiation therapy undetectable plasma EBV DNA for nasopharyngeal carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2016)

Overall Survival Benefits of First-Line Treatments for Asian Patients with Advanced Epidermal Growth Factor Receptor-Mutated NSCLC Harboring Exon 19 Deletion: A Systematic Review and Network Meta-Analysis
por: Chan, Sik-Kwan, et al.
Publicado: (2022)

Cost-Effectiveness of Intranasal Live-Attenuated Influenza Vaccine for Children: A Systematic Review
por: Chan, Kenneth Sik-Kwan, et al.
Publicado: (2022)

Nasopharynx Battlefield: Cellular Immune Responses Mediated by Midkine in Nasopharyngeal Carcinoma and COVID-19
por: Kam, Ngar-Woon, et al.
Publicado: (2023)

Negative plasma Epstein-Barr virus DNA nasopharyngeal carcinoma in an endemic region and its influence on liquid biopsy screening programmes
por: Nicholls, John Malcolm, et al.
Publicado: (2019)

First-Line Atezolizumab Plus Bevacizumab versus Sorafenib in Hepatocellular Carcinoma: A Cost-Effectiveness Analysis
por: Chiang, Chi-Leung, et al.
Publicado: (2021)

Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma
por: Ka-Yue Chow, Larry, et al.
Publicado: (2022)

Management of Nasopharyngeal Carcinoma in Elderly Patients
por: Chan, Wing Lok, et al.
Publicado: (2022)

Literature Review of Traditional Chinese Medicine Herbs–Induced Liver Injury From an Oncological Perspective With RUCAM
por: Chow, Hei Ching, et al.
Publicado: (2019)

Cost-effectiveness of Pembrolizumab as a Second-Line Therapy for Hepatocellular Carcinoma
por: Chiang, Chi-leung, et al.
Publicado: (2021)

Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma
por: Dai, Wei, et al.
Publicado: (2015)

Particle beam therapy for nasopharyngeal cancer: A systematic review and meta-analysis
por: Ng, Wai Tong, et al.
Publicado: (2022)

NF-κB p65 Subunit Is Modulated by Latent Transforming Growth Factor-β Binding Protein 2 (LTBP2) in Nasopharyngeal Carcinoma HONE1 and HK1 Cells
por: Kan, Rebecca, et al.
Publicado: (2015)

Test-retest reliability of a computer-assisted self-administered questionnaire on early life exposure in a nasopharyngeal carcinoma case-control study
por: Mai, Zhi-Ming, et al.
Publicado: (2018)

Tuberculosis reactivation at ileum following immune checkpoint inhibition with pembrolizumab for metastatic nasopharyngeal carcinoma: a case report
por: Lau, Kin-Sang, et al.
Publicado: (2021)

Dose-Response Reduction in Risk of Nasopharyngeal Carcinoma From Smoking Cessation: A Multicenter Case-Control Study in Hong Kong, China
por: Wang, Lijun, et al.
Publicado: (2021)

Dietary fiber intake from fresh and preserved food and risk of nasopharyngeal carcinoma: observational evidence from a Chinese population
por: MAI, Zhi-Ming, et al.
Publicado: (2021)

SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma: A Systematic Review and Pooled Analysis of Treatment Outcomes
por: Lee, Victor Ho-Fun, et al.
Publicado: (2022)

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report
por: Lee, Victor, et al.
Publicado: (2016)

Milk Consumption Across Life Periods in Relation to Lower Risk of Nasopharyngeal Carcinoma: A Multicentre Case-Control Study
por: Mai, Zhi-Ming, et al.
Publicado: (2019)

Functions of double‐negative B cells in autoimmune diseases, infections, and cancers
por: Chung, Michael King Yung, et al.
Publicado: (2023)

Targeting Epstein-Barr Virus in Nasopharyngeal Carcinoma
por: Hau, Pok Man, et al.
Publicado: (2020)

MicroRNA profiling study reveals miR-150 in association with metastasis in nasopharyngeal carcinoma
por: Yue, Patrick Ying-Kit, et al.
Publicado: (2017)

A novel Hsp90 inhibitor AT13387 induces senescence in EBV-positive nasopharyngeal carcinoma cells and suppresses tumor formation
por: Chan, King Chi, et al.
Publicado: (2013)

Ablative-Transarterial Radioembolization resulting in complete histopathological response of hepatocellular carcinoma in the resected liver specimen after salvage hepatectomy
por: Chung, Thomas Kam-Man, et al.
Publicado: (2021)

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma
por: Lee, Victor H. F., et al.
Publicado: (2016)

CR2Cancer: a database for chromatin regulators in human cancer
por: Ru, Beibei, et al.
Publicado: (2018)

Therapeutic evaluation of palbociclib and its compatibility with other chemotherapies for primary and recurrent nasopharyngeal carcinoma
por: Xue, Zhichao, et al.
Publicado: (2020)

A Comprehensive Overview of IoT-Based Federated Learning: Focusing on Client Selection Methods
por: Khajehali, Naghmeh, et al.
Publicado: (2023)

Metastasis-suppressing NID2, an epigenetically-silenced gene, in the pathogenesis of nasopharyngeal carcinoma and esophageal squamous cell carcinoma
por: Chai, Annie Wai Yeeng, et al.
Publicado: (2016)

EBV–encoded miRNAs can sensitize nasopharyngeal carcinoma to chemotherapeutic drugs by targeting BRCA1
por: Lung, Raymond Wai‐Ming, et al.
Publicado: (2020)

Mitochondrial-Targeted Therapy for Doxorubicin-Induced Cardiotoxicity
por: Wu, Bin Bin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0v8ir3vh2mp19vc9itha2ij493